Carnegie Investment Bank is proud to have acted as Joint Bookrunner in connection with SpinChip Diagnostics ASA’ successful NOK 43 million convertible loan issue.
SpinChip Diagnostics is a medical device company who has developed a proprietary platform focused on in vitro diagnostics (IVD) to develop diagnostic tests for acute and chronic cardiac indications where test results are rapidly needed to provide patients with life-saving treatments.
Carnegie congratulates Chair Åse Aulie Michelet, CEO Morten Jurs, CSO Stig Morten Borch, CFO Hamed Brodersen, the shareholders and the rest of the SpinChip team with the successful transaction. We look forward to continuing our support of SpinChip going forward.